SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318771-08-000019
Filing Date
2008-11-04
Accepted
2008-11-03 21:51:06
Documents
5
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 GENENTECH, INC. FORM 10-Q FOR THE PERIOD ENDING SEPTEMBER 30, 2008 dna-10q_q308.htm 10-Q 1815159
2 LETTER REGARDING UNAUDITED INTERIM FINANCIAL INFORMATION ex15_1.htm EX-15.1 4944
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14( ex31_1.htm EX-31.1 11529
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14( ex31_2.htm EX-31.2 11917
5 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT T ex32_1.htm EX-32.1 11661
  Complete submission text file 0000318771-08-000019.txt   1856602
Mailing Address 1 DNA WAY . SOUTH SAN FRANCISCO CA 94080
Business Address 1 DNA WAY SOUTH SAN FRANCISCO CA 94080 650-225-1000
GENENTECH INC (Filer) CIK: 0000318771 (see all company filings)

IRS No.: 942347624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-09813 | Film No.: 081159029
SIC: 2834 Pharmaceutical Preparations